David P. Richman
Affiliations: | Neuroscience | University of California, Davis, Davis, CA |
Area:
Neuroscience Biology, ImmunologyGoogle:
"David Richman"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Borges LS, Richman DP. (2020) Muscle-Specific Kinase Myasthenia Gravis. Frontiers in Immunology. 11: 707 |
| Richman DP. (2016) Lipoprotein-like receptor 4 antibodies in myasthenia gravis: pathogenic or protective. European Journal of Neurology. 23: 1593-1594 |
| Morell SW, Trinh VB, Gudipati E, et al. (2014) Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor. Molecular Immunology. 58: 116-31 |
| Richman DP, Nishi K, Ferns MJ, et al. (2012) Animal models of antimuscle-specific kinase myasthenia. Annals of the New York Academy of Sciences. 1274: 140-7 |
| Richman DP, Nishi K, Morell SW, et al. (2012) Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes. Archives of Neurology. 69: 453-60 |
| Richman DP. (2012) Antibodies to low density lipoprotein receptor-related protein 4 in seronegative myasthenia gravis. Archives of Neurology. 69: 434-5 |
| Kim JY, Park KD, Richman DP. (2011) Treatment of myasthenia gravis based on its immunopathogenesis. Journal of Clinical Neurology (Seoul, Korea). 7: 173-83 |
| Richman DP, Agius MA. (2003) Treatment of autoimmune myasthenia gravis. Neurology. 61: 1652-61 |
| Richman DP, Agius MA. (2003) Treatment principles in the management of autoimmune myasthenia gravis. Annals of the New York Academy of Sciences. 998: 457-72 |
| Agius MA, Richman DP, Fairclough RH, et al. (2003) Three forms of immune myasthenia. Annals of the New York Academy of Sciences. 998: 453-6 |